347 related articles for article (PubMed ID: 20433742)
1. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
Song B; Wang Y; Titmus MA; Botchkina G; Formentini A; Kornmann M; Ju J
Mol Cancer; 2010 Apr; 9():96. PubMed ID: 20433742
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of miR-215 in colon cancer.
Karaayvaz M; Pal T; Song B; Zhang C; Georgakopoulos P; Mehmood S; Burke S; Shroyer K; Ju J
Clin Colorectal Cancer; 2011 Dec; 10(4):340-7. PubMed ID: 21752725
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.
Song B; Wang Y; Xi Y; Kudo K; Bruheim S; Botchkina GI; Gavin E; Wan Y; Formentini A; Kornmann M; Fodstad O; Ju J
Oncogene; 2009 Nov; 28(46):4065-74. PubMed ID: 19734943
[TBL] [Abstract][Full Text] [Related]
4. mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.
Sowers R; Toguchida J; Qin J; Meyers PA; Healey JH; Huvos A; Banerjee D; Bertino JR; Gorlick R
Mol Cancer Ther; 2003 Jun; 2(6):535-41. PubMed ID: 12813132
[TBL] [Abstract][Full Text] [Related]
5. Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation.
Rushworth D; Mathews A; Alpert A; Cooper LJ
J Biol Chem; 2015 Sep; 290(38):22970-6. PubMed ID: 26242737
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
[TBL] [Abstract][Full Text] [Related]
7. Resistance to tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines.
Drake JC; Allegra CJ; Moran RG; Johnston PG
Biochem Pharmacol; 1996 May; 51(10):1349-55. PubMed ID: 8787551
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues.
Wang L; Wang YM; Xu S; Wang WG; Chen Y; Mao JY; Tian BL
Mol Med Rep; 2015 Oct; 12(4):5274-80. PubMed ID: 26135967
[TBL] [Abstract][Full Text] [Related]
9. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
Mishra PJ; Song B; Mishra PJ; Wang Y; Humeniuk R; Banerjee D; Merlino G; Ju J; Bertino JR
PLoS One; 2009 Dec; 4(12):e8445. PubMed ID: 20041160
[TBL] [Abstract][Full Text] [Related]
10. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
[TBL] [Abstract][Full Text] [Related]
11. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.
Song B; Wang Y; Kudo K; Gavin EJ; Xi Y; Ju J
Clin Cancer Res; 2008 Dec; 14(24):8080-6. PubMed ID: 19088023
[TBL] [Abstract][Full Text] [Related]
12. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells.
Arrebola R; Olmo A; Reche P; Garvey EP; Santi DV; Ruiz-Perez LM; Gonzalez-Pacanowska D
J Biol Chem; 1994 Apr; 269(14):10590-6. PubMed ID: 8144647
[TBL] [Abstract][Full Text] [Related]
14. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
Bhattacharya A; Leprohon P; Ouellette M
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.
Longley DB; Ferguson PR; Boyer J; Latif T; Lynch M; Maxwell P; Harkin DP; Johnston PG
Clin Cancer Res; 2001 Nov; 7(11):3533-9. PubMed ID: 11705873
[TBL] [Abstract][Full Text] [Related]
16. Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil.
Capiaux GM; Budak-Alpdogan T; Takebe N; Mayer-Kuckuk P; Banerjee D; Maley F; Bertino JR
Hum Gene Ther; 2003 Mar; 14(5):435-46. PubMed ID: 12691609
[TBL] [Abstract][Full Text] [Related]
17. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.
Xu W; Li Z; Zhu X; Xu R; Xu Y
Med Sci Monit; 2018 Dec; 24():8812-8821. PubMed ID: 30518744
[TBL] [Abstract][Full Text] [Related]
18. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
Zhang D; Ochi N; Takigawa N; Tanimoto Y; Chen Y; Ichihara E; Hotta K; Tabata M; Tanimoto M; Kiura K
Cancer Lett; 2011 Oct; 309(2):228-35. PubMed ID: 21742432
[TBL] [Abstract][Full Text] [Related]
19. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
[TBL] [Abstract][Full Text] [Related]
20. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
Magro PG; Russo AJ; Li WW; Banerjee D; Bertino JR
Cancer Res; 2004 Jun; 64(12):4338-45. PubMed ID: 15205349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]